In a 22-year-old transgender male (female-to-male) with two weeks of urinary urgency, frequency, incontinence, possible vaginal discharge, and urinalysis showing leukocyte esterase positive, nitrite negative, pH 8, specific gravity 1.010, how should this likely uncomplicated urinary tract infection be managed?

Management of Likely Uncomplicated UTI in a Transgender Male Patient

This patient should be treated empirically with first-line antibiotics for uncomplicated cystitis: either nitrofurantoin 100 mg twice daily for 5 days, fosfomycin 3g single dose, or trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days, based on the 2024 EAU guidelines for treatment in women with uncomplicated cystitis. 1

Clinical Reasoning

This 22-year-old transgender male (assigned female at birth, retaining female anatomy) presents with classic symptoms of uncomplicated cystitis: 2-week history of urgency, frequency, and incontinence following sexual activity with failure to void post-coitally. The urinalysis shows leukocyte esterase positive (25) with negative nitrites, pH 8, and specific gravity 1.010—a pattern consistent with UTI despite the nitrite-negative result.

Why This is Uncomplicated Cystitis

The patient meets criteria for uncomplicated cystitis per the 2024 EAU guidelines 1:

• Classic lower urinary tract symptoms (urgency, frequency, dysuria-equivalent incontinence)
• No fever, no CVA tenderness (excludes pyelonephritis)
• No anatomic/functional urinary tract abnormalities mentioned
• No significant comorbidities
• Retained female anatomy places them in the "women" treatment category

The diagnosis can be made clinically without culture based on typical symptoms and positive leukocyte esterase 1. The 2024 EAU guidelines explicitly state that in patients with typical symptoms, urine culture leads to "only a minimal increase in diagnostic accuracy" 1.

Addressing the Nitrite-Negative Result

The negative nitrite does NOT rule out UTI in this case. Here's why:

• Leukocyte esterase has 90% sensitivity for bacteriuria in adults 2
• Nitrite is only positive when gram-negative bacteria (primarily E. coli) have sufficient time to convert urinary nitrate to nitrite—typically requiring 4+ hours of bladder dwell time 3
• Among nitrite-negative UTIs, 95.6% are still caused by gram-negative organisms 3
• Only 3.2% of nitrite-negative UTIs are caused by enterococcus (which doesn't produce nitrite) 3
• The alkaline pH (8.0) actually supports bacterial infection, as many uropathogens alkalinize urine

The Vaginal Discharge Concern

The possible vaginal discharge requires brief consideration. The 2024 EAU guidelines note that absence of vaginal discharge increases the probability of cystitis diagnosis 1. However:

• The patient describes uncertainty about whether discharge is "normal lochia" (suggesting recent childbirth/postpartum status, though this seems inconsistent with the clinical picture)
• The patient is not concerned about STIs and has a female partner
• The predominant symptoms are urinary (urgency, frequency, incontinence), not vaginal
• Leukocyte esterase positivity strongly supports urinary inflammation

If significant vaginal discharge is present on examination, consider concurrent vaginitis, but the urinary symptoms still warrant UTI treatment.

Recommended Treatment Algorithm

First-Line Options (Choose ONE):

1. Nitrofurantoin 100 mg PO twice daily × 5 days 1, 4

   • Excellent choice: minimal resistance, spares broader-spectrum agents
   • Avoid if GFR <30 mL/min

2. Fosfomycin trometamol 3g PO single dose 1, 4

   • Convenient single-dose therapy
   • Specifically recommended for women with uncomplicated cystitis

3. Trimethoprim-sulfamethoxazole 160/800 mg PO twice daily × 3 days 1, 4

   • Only if local E. coli resistance <20%
   • Avoid in first trimester pregnancy (not applicable here)

Alternative Options (if first-line unavailable or contraindicated):

• Cephalosporins (e.g., cefadroxil 500 mg twice daily × 3 days) if local E. coli resistance <20% 1
• Pivmecillinam 400 mg three times daily × 3-5 days (if available) 1

Do NOT Use:

• Fluoroquinolones as first-line (reserve for pyelonephritis or resistant organisms) 4
• β-lactams alone (less effective than other options) 5

When to Obtain Urine Culture

Culture is NOT needed for initial treatment in this case 1. The 2024 EAU guidelines recommend culture only for:

• Suspected pyelonephritis (not present here)
• Symptoms not resolving or recurring within 4 weeks after treatment
• Women with atypical symptoms (the vaginal discharge concern could qualify)
• Pregnancy

Consider obtaining culture if:

• The vaginal discharge is confirmed significant on examination
• Symptoms persist beyond 2-3 days of appropriate therapy
• Symptoms recur within 2 weeks (suggesting resistant organism) 1

Critical Follow-Up Points

1. If symptoms don't resolve by end of treatment: Obtain culture and susceptibility testing, assume resistance to initial agent, retreat with 7-day course of different antibiotic 1

2. Post-treatment culture is NOT indicated if asymptomatic 1

3. Counsel on prevention: Post-coital voiding (which was missed before symptom onset), adequate hydration, avoid spermicides if used 6

4. Address the 2-week duration: This is longer than typical acute cystitis. If symptoms persist despite treatment, consider:

   • Resistant organism (obtain culture)
   • Complicated infection
   • Alternative diagnosis (interstitial cystitis, pelvic floor dysfunction)

Common Pitfalls to Avoid

• Don't withhold treatment because nitrites are negative—leukocyte esterase alone with symptoms is sufficient 1, 7
• Don't treat as "complicated" just because patient is transgender—retained female anatomy = treat as uncomplicated cystitis in women 1
• Don't order culture routinely—it's unnecessary for straightforward uncomplicated cystitis 1
• Don't use 7-day regimens for uncomplicated cystitis—short-course therapy (3-5 days) is equally effective with fewer adverse effects 4, 8
• Don't assume vaginal discharge rules out UTI—they can coexist, and urinary symptoms predominate here